Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer.
Gang CaiLu CaoYoulia M KirovaYan FengJia-Yi ChenPublished in: Radiation oncology (London, England) (2019)
Concurrent RT and weekly paclitaxel could be an effective therapeutic option for unresectable locoregionally recurrent breast cancer after mastectomy with an acceptable toxicity profile.